Aurobindo Pharma has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported over 2-fold jump in its net profit at Rs 335.95 crore for the quarter under review as compared to Rs 122.16 crore for the same quarter in the previous year. Total income of the company increased by 39.68% at Rs 2,485.70 crore for Q1FY24 as compared Rs 1,779.53 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 9.48% rise in its net profit at Rs 569.71 crore for the first quarter ended June 30, 2023 as compared to Rs 520.38 crore for the same quarter in the previous year. Total income of the company increased by 11% at Rs 6,966.85 crore for Q1FY24 as compared Rs 6,276.54 crore for the corresponding quarter previous year.
